Hidden Herpesvirus May Accelerate Alzheimer’s Through T Cells

Viruses that never truly leave us might be nudging our aging brains down a darker path. That is the unsettling idea emerging from a new study out of Cardiff University: persistent herpesvirus infection can stoke immune activity in the brain and, in mice genetically primed for Alzheimer’s, speed cognitive decline.

Think of it like an unwelcome guest who keeps returning and, each time, sets off the household alarm. The alarm is the immune system. The guest is a β-herpesvirus—murine cytomegalovirus (MCMV) in the experiments—capable of lying dormant for years and flaring up intermittently. Researchers asked what happens when those flare-ups repeatedly summon T cells into brain tissue already vulnerable to Alzheimer’s pathology.

The team worked with 3xTg-AD mice, a laboratory model carrying mutations that produce hallmark Alzheimer’s features: memory loss, hippocampal neuron loss, and the buildup of amyloid and tau proteins. After infecting these animals with MCMV, they tracked behavior, brain pathology, and immune cell traffic. The result was striking. Mice with persistent infection displayed worsened memory and accelerated neural damage compared with their uninfected counterparts.

Close inspection revealed why. Large numbers of virus-specific CD8+ T cells migrated into the brain. These are not casual bystanders. They seek out and destroy infected cells. In doing so, they can release inflammatory signals and cytotoxic molecules—effective at stopping virus spread but hazardous when their activity is sustained in delicate brain tissue.

MCMV infection exacerbates cognitive decline in 3xTg-AD mice. 

“Infections, including chronic human herpesviruses, which can be associated with cold sores, have long been suspected as increasing the risk of developing Alzheimer’s disease,” explains Dr. Mathew Clement of Cardiff University’s School of Medicine. “But the mechanisms behind that link were unclear. Our work points to T cells as active players in the story.”

To test whether the immune response itself was the culprit, the researchers interrupted it in two ways. Some mice received the antiviral valganciclovir hydrochloride to suppress viral replication. Others were treated with antibodies that depleted CD4 and CD8 T cells. Both approaches yielded a common outcome: preserved cognition. Treated animals performed better in memory tests, and markers of neuronal loss and protein aggregation were reduced.

Put simply, tamping down the virus or dialing back T cell activity improved brain outcomes. That suggests the immune system’s prolonged engagement with a latent virus—rather than the virus alone—can actively accelerate Alzheimer’s-like pathology. Similar virus-recognizing T cells have been observed in the brains and cerebrospinal fluid of people with Alzheimer’s, but this study draws a clearer causal line, at least in a mouse model.

Professor Ian Humphreys, Professor of Viral Pathogenesis and co-director at Cardiff’s Systems Immunity Research Institute, cautions that the exact molecular choreography remains to be mapped. How do virus-specific T cells damage neurons? Do they trigger local inflammation that compromises synapses and protein clearance? These are the next questions, and answering them could reveal new targets for intervention.

There are immediate and broader implications. If chronic herpesviruses can nudge neurodegeneration through immune-mediated pathways, then prevention—vaccines, timely antiviral therapy, even strategies to modulate T cell activity—may carry long-term benefits beyond avoiding a cold sore. This study adds weight to the idea that dementia risk reflects not only genes, but a lifetime of environmental exposures, infections included. Prevention today might look like protection for decades to come.

The research appears in Brain (2026) and is indexed under DOI: 10.1093/brain/awag043. It doesn’t resolve every question, but it does refocus attention on the immune system’s double-edged role in the aging brain and opens a pathway toward treatments that address infection-driven inflammation rather than amyloid or tau alone.

If a sleeping virus can tug at the threads of memory, perhaps the best defense is to stop it from waking up.